← Browse by Condition
Medical Condition

advanced ovarian carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05472857 Phase 1
Recruiting

Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression

Enrollment
30 pts
Location
China
Sponsor
Suzhou Immunofoco Biotechnolog...
View Trial →